161 related articles for article (PubMed ID: 35390147)
21. Clinical Analysis and Mental Health Survey of Hemophilia Carriers: a Cross-sectional Study.
Wang W; Jiang LJ; Cui DY; Zhang A; Wang X; Liu AG; Hu Q
Curr Med Sci; 2024 Apr; 44(2):435-440. PubMed ID: 38561593
[TBL] [Abstract][Full Text] [Related]
22. Targeting anticoagulant protein S to improve hemostasis in hemophilia.
Prince R; Bologna L; Manetti M; Melchiorre D; Rosa I; Dewarrat N; Suardi S; Amini P; Fernández JA; Burnier L; Quarroz C; Reina Caro MD; Matsumura Y; Kremer Hovinga JA; Griffin JH; Simon HU; Ibba-Manneschi L; Saller F; Calzavarini S; Angelillo-Scherrer A
Blood; 2018 Mar; 131(12):1360-1371. PubMed ID: 29317453
[TBL] [Abstract][Full Text] [Related]
23. Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels.
Kiouptsi K; Grill A; Mann A; Döhrmann M; Lillich M; Jäckel S; Malinarich F; Formes H; Manukyan D; Subramaniam S; Khandagale A; Karwot C; Thal SC; Bosmann M; Scharrer I; Jurk K; Reinhardt C
PLoS One; 2017; 12(8):e0183590. PubMed ID: 28837614
[TBL] [Abstract][Full Text] [Related]
24. Coagulation Testing in the Core Laboratory.
Winter WE; Flax SD; Harris NS
Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
[TBL] [Abstract][Full Text] [Related]
25. X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.
Garagiola I; Mortarino M; Siboni SM; Boscarino M; Mancuso ME; Biganzoli M; Santagostino E; Peyvandi F
Eur J Hum Genet; 2021 Feb; 29(2):241-249. PubMed ID: 33082527
[TBL] [Abstract][Full Text] [Related]
26. A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia A.
Muczynski V; Verhenne S; Casari C; Chérel G; Panicot-Dubois L; Gueguen P; Trossaert M; Dubois C; Lenting PJ; Denis CV; Christophe OD
Thromb Haemost; 2019 Dec; 119(12):1981-1993. PubMed ID: 31639831
[TBL] [Abstract][Full Text] [Related]
27. Hemophilia A and B mice, but not VWF
Taves S; Sun J; Livingston EW; Chen X; Amiaud J; Brion R; Hannah WB; Bateman TA; Heymann D; Monahan PE
Sci Rep; 2019 Oct; 9(1):14428. PubMed ID: 31594977
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of factor VII ameliorates bleeding diathesis of factor VIII-deficient mice with inhibitors.
Yasumoto A; Madoiwa S; Kashiwakura Y; Ishiwata A; Ohmori T; Mizukami H; Ozawa K; Sakata Y; Mimuro J
Thromb Res; 2013 May; 131(5):444-9. PubMed ID: 23566532
[TBL] [Abstract][Full Text] [Related]
29. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of non-anticoagulant activated protein C variant (D36A/L38D/A39V) in a murine model of ischaemic stroke.
Andreou AP; Efthymiou M; Yu Y; Watts HR; Noormohamed FH; Ma D; Lane DA; Crawley JT
PLoS One; 2015; 10(4):e0122410. PubMed ID: 25830552
[TBL] [Abstract][Full Text] [Related]
31. An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia.
Sehgal A; Barros S; Ivanciu L; Cooley B; Qin J; Racie T; Hettinger J; Carioto M; Jiang Y; Brodsky J; Prabhala H; Zhang X; Attarwala H; Hutabarat R; Foster D; Milstein S; Charisse K; Kuchimanchi S; Maier MA; Nechev L; Kandasamy P; Kel'in AV; Nair JK; Rajeev KG; Manoharan M; Meyers R; Sorensen B; Simon AR; Dargaud Y; Negrier C; Camire RM; Akinc A
Nat Med; 2015 May; 21(5):492-7. PubMed ID: 25849132
[TBL] [Abstract][Full Text] [Related]
32. Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.
Stagaard R; Ley CD; Almholt K; Olsen LH; Knudsen T; Flick MJ
Blood Adv; 2018 Nov; 2(22):3126-3136. PubMed ID: 30459211
[TBL] [Abstract][Full Text] [Related]
33. EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.
Magisetty J; Pendurthi UR; Esmon CT; Rao LVM
Blood; 2020 Jun; 135(25):2211-2223. PubMed ID: 32294155
[TBL] [Abstract][Full Text] [Related]
34. Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding.
Hoffman M
Blood Adv; 2021 Sep; 5(18):3736. PubMed ID: 34581771
[TBL] [Abstract][Full Text] [Related]
35. Thrombin spatial distribution determines protein C activation during hemostasis and thrombosis.
Marar TT; Matzko CN; Wu J; Esmon CT; Sinno T; Brass LF; Stalker TJ; Tomaiuolo M
Blood; 2022 Mar; 139(12):1892-1902. PubMed ID: 34890454
[TBL] [Abstract][Full Text] [Related]
36. B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin.
Biswas M; Palaschak B; Kumar SRP; Rana J; Markusic DM
Front Immunol; 2020; 11():1293. PubMed ID: 32670285
[TBL] [Abstract][Full Text] [Related]
37. Major differences in bleeding symptoms between factor VII deficiency and hemophilia B.
Bernardi F; Dolce A; Pinotti M; Shapiro AD; Santagostino E; Peyvandi F; Batorova A; Lapecorella M; Schved JF; Ingerslev J; Mariani G;
J Thromb Haemost; 2009 May; 7(5):774-9. PubMed ID: 19245420
[TBL] [Abstract][Full Text] [Related]
38. Activated protein C has a regulatory role in factor VIII function.
Wilhelm AR; Parsons NA; Samelson-Jones BJ; Davidson RJ; Esmon CT; Camire RM; George LA
Blood; 2021 May; 137(18):2532-2543. PubMed ID: 33512448
[TBL] [Abstract][Full Text] [Related]
39. Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream.
Neumeyer J; Lin RZ; Wang K; Hong X; Hua T; Croteau SE; Neufeld EJ; Melero-Martin JM
Blood Adv; 2019 Dec; 3(24):4166-4176. PubMed ID: 31851760
[TBL] [Abstract][Full Text] [Related]
40. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
